Home › Idiopathic Pulmonary Fibrosis
Pag-aaral pangklinika para sa Idiopathic Pulmonary Fibrosis na nagre-recruit sa U.S.
27 pag-aaral para sa Idiopathic Pulmonary Fibrosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Birmingham, AL9 pag-aaral
- New York City, NY8 pag-aaral
- Los Angeles, CA7 pag-aaral
- Kansas City, KS7 pag-aaral
- Philadelphia, PA7 pag-aaral
- Durham, NC6 pag-aaral
- Chicago, IL6 pag-aaral
- Aurora, CO6 pag-aaral
- Atlanta, GA5 pag-aaral
- Charleston, SC5 pag-aaral
- Dallas, TX5 pag-aaral
- Nashville, TN5 pag-aaral
- Detroit, MI5 pag-aaral
- Houston, TX5 pag-aaral
- Baltimore, MD4 pag-aaral
- Oklahoma City, OK4 pag-aaral
- Ann Arbor, MI4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Newport Beach, CA4 pag-aaral
- Winston-Salem, NC4 pag-aaral
- El Paso, TX4 pag-aaral
- Denver, CO3 pag-aaral
- Boston, MA3 pag-aaral
- Pittsburgh, PA3 pag-aaral
- Champaign, IL3 pag-aaral
- Greensboro, NC3 pag-aaral
- Denison, TX3 pag-aaral
- Charlottesville, VA3 pag-aaral
- Orlando, FL3 pag-aaral
- Richmond, VA3 pag-aaral
- Arlington, VA3 pag-aaral
- New Haven, CT3 pag-aaral
- Mountain View, CA3 pag-aaral
- Cincinnati, OH3 pag-aaral
Ayos sa estado
- Alabama9 pag-aaral
- Arizona5 pag-aaral
- California12 pag-aaral
- Colorado9 pag-aaral
- Connecticut4 pag-aaral
- Florida10 pag-aaral
- Georgia5 pag-aaral
- Illinois8 pag-aaral
- Kansas7 pag-aaral
- Kentucky3 pag-aaral
- Louisiana4 pag-aaral
- Maryland4 pag-aaral
- Massachusetts4 pag-aaral
- Michigan7 pag-aaral
- Missouri6 pag-aaral
- New York8 pag-aaral
- North Carolina10 pag-aaral
- Ohio5 pag-aaral
- Oklahoma4 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania12 pag-aaral
- South Carolina8 pag-aaral
- Tennessee6 pag-aaral
- Texas11 pag-aaral
- Utah5 pag-aaral
- Virginia8 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07652658A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07516951Pulmonary Fibrosis Foundation Community Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05382572RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07230288Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05571059Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT00373841Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT01915511Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 1
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT04362644Dose-Escalation Study of Artesunate Patients With IPF
Nagre-recruitPhase 1
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05988463WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06967805H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06325696Interstitial Lung Disease Research Unit Biobank
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05392881A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT00470327Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 45 hanggang 90 · Lahat ng kasarian · Na-update May 1, 2026 · NCT03297775Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Nagre-recruitPhase 1/2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ene 13, 2026 · NCT03500731Mechanisms of Familial Pulmonary Fibrosis
Nagre-recruitObservasyonal na pag-aaral
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Dis 31, 2025 · NCT03437486Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT01776398Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Nob 10, 2025 · NCT06567717Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT06853145Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.